SCHEMBL20127624

SCHEMBL20127624

c1cc(-c2c3ccccc3c(-c3ccc4oc5c(ccc6c7ccccc7oc65)c4c3)c3ccccc23)cc(-c2cc3ccccc3c3ccccc23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.44
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
PLA2G10 O15496 1/20 0.37
CYP11B1 P15538 1/20 0.37
GGPS1 O95749 1/20 0.36
PRKDC P78527 1/20 0.36
GPR84 Q9NQS5 2/20 0.35
MAPT P10636 4/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122427 0.94 ALOX5 (0.40) ALOX5PLA2G2APLA2G4APLA2G10CYP11B1
SCHEMBL20127615 0.92 ALOX5 (0.40) ALOX5CYP11B1PRKDCGPR84MAPT
SCHEMBL25052926 0.92 ALOX5 (0.46) ALOX5PLA2G2APLA2G4APLA2G10CYP11B1
SCHEMBL25052523 0.92 ALOX5 (0.46) ALOX5PLA2G2APLA2G4APLA2G10CYP11B1
SCHEMBL24090217 0.92 MAPT (0.41) ALOX5PLA2G2APLA2G4APLA2G10CYP11B1
SCHEMBL16067534 0.91 KDM4E (0.39) ALOX5CYP11B1PRKDCMAPTKDM4E
SCHEMBL12578229 0.91 PLA2G2A (0.40) ALOX5PLA2G2APLA2G4APLA2G10CYP11B1
SCHEMBL13991451 0.91 PLA2G2A (0.42) ALOX5PLA2G2APLA2G4APLA2G10CYP11B1
SCHEMBL10122387 0.91 ALOX5 (0.41) ALOX5PLA2G2APLA2G4ACYP11B1PRKDC
SCHEMBL1637397 0.91 ALOX5 (0.43) ALOX5PLA2G2APLA2G4APLA2G10CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885PLA2G2A 2960/4885PLA2G4A 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.